Generic drugmaker Lupin has received U.S. Food and Drug Administration approval for its abbreviated new drug applications for ...

Lupin has received USFDA approval for generic diabetes medications, specifically Liraglutide Injection and Glucagon for ...

Lupin receives USFDA approval for generic Liraglutide Injection and Glucagon, expanding access to diabetes treatments.

Lupin receives US FDA approvals for liraglutide and Glucagon injectable products: Our Bureau, Mumbai Thursday, July 24, 2025, 12:20 Hrs [IST] Global pharma major Lupin Limited (Lu ...

Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ...

In this randomized controlled trial, weekly administration of Mazdutide resulted in significant weight reduction in adults ...